Literature DB >> 1100307

Temporal variations in acetaminophen and phenacetin half-life in man.

C A Shively, E S Vesell.   

Abstract

Acetaminophen (APAP) and phenacetin mean plasma half-lives were approximately 15% longer in normal male volunteers at 6 A.M. than at 2 P.M. as determined after oral administration of each drug at 6 A.M. and 2 P.M. Concentrations of plasma 11-hydroxycorticoids (11-OHCS) in these volunteers were approximately 42% higher at 6 A.M. than at 2 P.M. The mean apparent volume of distribution (aVd) of APAP decreased by approximately 13% from 6 A.M. to 2 P.M., whereas the mean metabolic clearance rate (MCR) of APAP did not change significantly. Neither the mean aVd nor the mean MCR of phenacetin changed significantly from 6 A.M. to 2 P.M. Measurement of urinary metabolites showed no alteration in APAP glucuronidation in the 8-hr period following APAP administration at 6 A.M. or 2 P.M., but indicated that after phenacetin administration 10% more of the dose was oxidatively metabolized to APAP during a 24-hr period beginning at 2 P.M. than at 6 A.M. Within each subject, plasma acetaminophen or phenacetin half-life at 2 P.M. or 6 A.M. was highly reproducible, but large interindividual variations occurred in the extent of temporal variation during this period.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100307     DOI: 10.1002/cpt1975184413

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  25 in total

Review 1.  Altered hepatic blood flow and drug disposition.

Authors:  A S Nies; D G Shand; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

2.  Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.

Authors:  M E Veronese; S McLean
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

4.  Circadian variation in the pharmacokinetics of verapamil.

Authors:  C M Jespersen; M Frederiksen; J F Hansen; N A Klitgaard; C Sørum
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 5.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

6.  Influence of the Time of Intravenous Administration of Paracetamol on its Pharmacokinetics and Ocular Disposition in Rabbits.

Authors:  Agnieszka Karbownik; Agnieszka Bienert; Włodzimierz Płotek; Tomasz Grabowski; Magdalena Cerbin-Koczorowska; Anna Wolc; Edmund Grześkowiak
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

7.  The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition.

Authors:  H W Devonshire; I Kong; M Cooper; T P Sloan; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

8.  Time-dependent variations in the organ extraction ratios of acetaminophen in rat.

Authors:  P M Bélanger; M Lalande; F Doré; G Labrecque
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

9.  Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs.

Authors:  E Perucca; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

10.  Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.

Authors:  L E Fisher; E A Ludwig; J A Wald; R R Sloan; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1992-06       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.